Journals / KSÜ Tıp Fakültesi Dergisi / 2005 / Cilt: 2 - Sayı: 1

The activities of leukocytes myeloperoxidase and superoxide dismutase in non-genital warts

Genital olmayan verrüde lökosit myeloperoksidaz ve süperoksit dismutaz aktiviteleri

Pages
1–4
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Moreover, it may be thought that it could be successful in HPV infections, due to the antiviral effects of MPO to be implemented locally for the purpose of treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Warts, is a common infection disease caused by Human papilloma virus (HPV).
📊
Key Findings & Data:Materials and Methods: In this study, 31 consecutive patients with warts (15 female, 16 male) and 34 healthy cases having no disease were attended.
💡
Conclusion & Impact:Moreover, it may be thought that it could be successful in HPV infections, due to the antiviral effects of MPO to be implemented locally for the purpose of treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Süperoksit dismutaz · Peroksidaz · Papillomavirus enfeksiyonları

Abstract

Objective: Warts, is a common infection disease caused by Human papilloma virus (HPV). The role of polimorphonuclear leukocytes (PMN) are unclear in the pathogenesis of warts. Two cytoplasmic enzymes, Myeloperoxidase (MPO) and Superoxide dismutase (Cu-Zn SOD) protect the cells against oxidant activity. In this study, we aim to determine the activities of MPO and Cu-Zn SOD in patients with non-genital warts. Materials and Methods: In this study, 31 consecutive patients with warts (15 female, 16 male) and 34 healthy cases having no disease were attended. Genital and filiformis warts were excluded from the study. The patients according to the types, the durations, the numbers, and the localizations of lesions were classified. The activities of Cu-Zn SOD and MPO in PMN were measured as spectrophotometrically. Results: There were no Cu-Zn SOD and MPO activities in patients with warts statistically significant compared to the control cases (p>0.05). Besides, these each enzyme activities were not correlated statistically among the types, the durations, the numbers, and the localizations of lesions (p>0.05). Conclusion: No changed Cu-Zn SOD activities indicate that oxidative stress in neutrophils does not occur in patients with non-genital warts. No difference MPO activities remind that this enzyme does not have a role in the regression of warts. Moreover, it may be thought that it could be successful in HPV infections, due to the antiviral effects of MPO to be implemented locally for the purpose of treatment.

Özet

Amaç: Verrü (siğil), İnsan papilloma virüsünün neden olduğu, deri ve mukozaları etkileyen, yaygın bir infeksiyon hastalığıdır. Hastalığın patogenezinde polimorfonükleer lökositlerin (PML) rolü açık değildir. Myeloperoksidaz (MPO) ve Süperoksit dismutaz (Cu-Zn SOD) iki önemli sitoplazmik enzim olup hücreyi oksidan aktiviteye karşı korurlar. Bu çalışmada bir grup genital olmayan verrülü hastada, hastalık ile MPO ve Cu-Zn SOD aktiviteleri arasındaki ilişki araştırılmıştır. Materyal ve Metot: Çalışmaya 15'i kadın 31 verrü hastası ile 34 kontrol olgusu katıldı. Filiformis ve genital verrükalı hastalar çalışmaya alınmadı. Hastalar hastalığın süresine, lezyonlann sayısına, tipine, lezyonların yerleşim yerlerine göre gruplandırıldı. Olguların lökosit Cu-Zn SOD ve MPO düzeyleri spektrofotometrik olarak ölçüldü. Bulgular: Hasta ve kontrol grubun arasında ortalama Cu-Zn SOD ve MPO düzeyleri arasında bir fark yoktu (p>0.05). Ayrıca hastalığın tipi, süresi, lezyonların sayısı ve dağılımı ile bunların herbirinin ortalama düzeyleri arasında istatistiksel anlamlı fark ve korelasyon bulunamadı (p>0.05). Sonuç: Genital olmayan verrülü hastalarda Cu-Zn SOD aktivitesinin değişmemesi bu hastalann lökositlerinde oksidatif stresin oluşmadığını göstermektedir. MPO aktivitesinin de farklı bulunmaması, bu enzimin verrünün gerilemesinde rolü olmadığını düşündürmüştür. Bununla birlikte HPV infeksiy onlarının tedavisinde antiviral etkisi nedeniyle MPO'dan lokal olarak yararlanılabileceği düşünülebilir.

🔖

Cite This Article

ARICAN, Ö., KURUTAŞ, E. B., ŞAŞMAZ, S. (2005). The activities of leukocytes myeloperoxidase and superoxide dismutase in non-genital warts. KSÜ Tıp Fakültesi Dergisi, Cilt: 2 - Sayı: 1, 1–4. https://ajindex.com/articles/274547

References (1)

  1. Bolton RA. Nongenital warts: Classification and treatment options. Am Fam Physician 1991; 43: 2049-56. 2.Sanclemente G, Gill DK. Human papillomavirus molecular biology and pathogenesis. J Eur Acad Dermatol Venereol 2002; 16: 231-40. 3.Leman JA, Benton EC. Verrucas. Guidelines for management. Am J Clin Dermatol 2000; 1: 143-9. 4.Verbov J. How to manage warts. Arch Dis Child 1999; 80: 97-9. 5.Campbell BJ. The treatment of warts. Primary Care 1986; 13:465-76. 6.James MP, Collier PM, Aberne W, Hardcastle A, Lovegrove S. Histologic, pharmacologic, and immunocytochemical effects of injection of bleomycin into viral warts. J Am Acad Dermatol 1993; 28: 933-7. 7.Uchimura K, Nagasaka A, Hayashi R, Makino M, Nagata M, Kakizawa H, Kobayashi T, Fujiwara K, Kato T, Iwase K, Shinohara R, Kato K, Itoh M. Changes in uperoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus. J Diab Comp 1999; 13: 264-70. 8.Splettstoesser WD, Schuff-Werner P. Oxidative stress in phagocytes: "The enemy within". Microsc Res Tech 2002; 57: 441-5. 9.Lanza F. Clinical manifestation of myeloperoxidase deficiency. J Mol Med 1998; 76: 676-81. 10.Pugliese PT. The skin's antioxidant systems. Dermatol Nurs 1998; 10: 401-16. 9.Lowry OH, Rosebrough NJ, Farr AL. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-75. 11.Worthington Enzyme Manual Worthington Biochemical Corporation Freehold, New Jersey, U.S.A., 1972. 12.Fridovich I. Superoxide dismutase. Adv Enzymol Relat Areas Mol Biol 1974; 41: 35-97. 13.Forslund O, Lindelöf B, Hradil E, Nordin P, Stenquist B, Kirnbauer, Slupetzky K, Dillner J. High prevalance of cutaneous human papillomavirus DNA on the top of skin tumors but not in "stripped" biopsies from same tumors. J Invest Dermatol 2004; 123: 388-94. 14.Stockfelt E, Nindl I, Sterry W, Ulrich C, Schmook T, Meyer T. Human papillomaviruses in transplant-associated skin cancers. Dermatol Surg 2004; 30: 604-9. 15.Arıcan Ö. Verrukalarda güncel tedavi. Dermatose 2004;3: 153-9. 16.Razumovitch JA, Fuchs D, Semenkova GN, Cherenkevich SN. Influence of neopterin on generation of reactive species by myeloperoxidase in human neutrophils. Biochim Biophys Acta 2004; 1672:46-50. 17.El Messaoudi K, Verheyden AM, Thirty L, Fourez S, Tasiaux N, Bollen A, Moguilevsy N. Human recombinant myeloperoxidase antiviral activity on Cytomegalovirus. J Med Virol 2002; 66: 218-23.